FindTrial
Sign In

A clinical study of zinc supplementation in children with fast breathing and breathing difficulty

Zinc Supplementation in Acute Lower Respiratory Tract Infection in Children: A Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000040
Enrollment
Unknown
Registered
2009-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Zinc: 20 mg once a day orally for 5 days Control Intervention1: Placebo:

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 2-24 months presenting with tachypnoea and either chest retractions or one of the following danger signs: cyanosis, inability to feed/drink, lethargy and convulsions

Exclusion criteria

Exclusion criteria: Children with concurrent diarrhea, severe malnutrition (weight for age <50% of reference value), congenital heart disease and those already on zinc supplements were excluded

Design outcomes

Primary

MeasureTime frame
Time to be asymptomaticTimepoint: defined as resolution of all four of the following: respiratory distress, tachypnoea, hypoxia in room air and systemic danger signs—

Secondary

MeasureTime frame
Duration of hospital stayTimepoint: measured at discharge from hospital—

Countries

India

Contacts

Public ContactDeepak Chawla

Government Medical College Hospital

drdeepakchawla@hotmail.com0172-2665253-60-2503

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026